Cargando…
COVID-19 Outcomes Among Racial and Ethnic Minority Individuals With Inflammatory Bowel Disease in the United States
The coronavirus disease 2019 (COVID-19) has affected more than 29 million people and led to more than 542,000 deaths in the United States.(1) Older age, comorbidities, and racial and ethnic minority status are associated with severe COVID-19.(2) Among patients with inflammatory bowel disease (IBD),...
Autores principales: | Agrawal, Manasi, Brenner, Erica J., Yan Mak, Joyce Wing, Zhang, Xian, Kaplan, Gilaad G., Ng, Siew C., Reinisch, Walter, Steinwurz, Flavio, Lewis, James D., Kissous-Hunt, Michele, Modesto, Irene, Ungaro, Ryan C., Colombel, Jean-Frederic, Kappelman, Michael D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the AGA Institute
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8169727/ https://www.ncbi.nlm.nih.gov/pubmed/34089848 http://dx.doi.org/10.1016/j.cgh.2021.05.060 |
Ejemplares similares
-
Fr509 COVID-19 OUTCOMES AMONG RACIAL AND ETHNIC MINORITY INDIVIDUALS WITH INFLAMMATORY BOWEL DISEASES IN THE UNITED STATES
por: Agrawal, Manasi, et al.
Publicado: (2021) -
Sa502 THE FIRST AND SECOND WAVE OF COVID-19 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A TEMPORAL TREND ANALYSIS
por: Kaplan, Gilaad, et al.
Publicado: (2021) -
The Multiple Waves of COVID-19 in Patients With Inflammatory Bowel Disease: A Temporal Trend Analysis
por: Kaplan, Gilaad G, et al.
Publicado: (2022) -
Physician Practice Patterns in Holding Inflammatory Bowel Disease Medications due to COVID-19, in the SECURE-IBD Registry
por: Agrawal, Manasi, et al.
Publicado: (2020) -
Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry
por: Brenner, Erica J., et al.
Publicado: (2020)